Forbes·1 min read·medium

FDA Approves First mRNA Flu Vaccine For Older Adults - Forbes

S
Siladitya Ray
FDA Approves First mRNA Flu Vaccine For Older Adults - Forbes
AI Summary

The FDA has granted approval for the first mRNA-based influenza vaccine specifically designed for older adults. This development follows previous regulatory scrutiny regarding the agency's vaccine approval processes.

The U.S. Food and Drug Administration approved the countrys first mRNA-based flu vaccine for older adults, months after the regulator faced backlash from medical professionals and scientists for refu…

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in